Enhanced safety and efficacy profile of CD40 antibody upon encapsulation in pHe-triggered membrane-adhesive nanoliposomes
- 29 December 2024
- journal article
- research article
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (2) , 155-166
Abstract
To develop pH (pHe)-triggered membrane adhesive nanoliposome (pHTANL) of CD40a to enhance anti-tumor activity in pancreatic cancer while reducing systemic toxicity. A small library of nanoliposomes (NL) with various lipid compositions were synthesized to prepare pH (pHe)-triggered membrane adhesive nanoliposome (pHTANL). Physical and functional characterization of pHTANL-CD40a was performed via dynamic light scattering (DLS), Transmission Electron Microscopy (TEM), confocal microscopy, and flow cytometry. In vivo studies were performed using PDAC (Panc02) transplanted mice. Tumor tissue was analyzed by flow cytometry, and plasma cytokines and liver enzymes were analyzed by ELISA. pHTANL-CD40a reduced tumor growth, enhanced tumor immune infiltration/activation, and enhanced survival compared to vehicle and free-CD40a. Importantly, pHTANL-CD40a treatment resulted in significantly lower systemic toxicity as indicated by unchanged body weight, minimal organ deformity, and reduced serum levels of liver enzyme alanine transaminase (ALT) and inflammatory cytokine IL-6. pHTANL-CD40a is more effective than free CD40a in anti-tumor activity, especially in altering the TME immune landscape for a potential therapeutic benefit in combination with immunotherapy.Keywords
Funding Information
- National Institutes of Health NCI (R01CA247370)
This publication has 53 references indexed in Scilit:
- Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic CancerAdvanced Science, 2023
- Senescence-associated secretory proteins induced in lung adenocarcinoma by extended treatment with dexamethasone enhance migration and activation of lymphocytesCancer Immunology, Immunotherapy, 2022
- Injectable Nanoparticle‐Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist AntibodiesAdvanced Science, 2022
- Smart pH-responsive nanomedicines for disease therapyJournal of Pharmaceutical Investigation, 2022
- Review of immune checkpoint inhibitors in immuno-oncology2021
- Pancreatic cancer treatment: better, but a long way to goSurgery Today, 2020
- Immunotherapy for pancreatic cancer: Barriers and breakthroughsAnnals of Gastroenterological Surgery, 2018
- Lipid-functionalized Dextran Nanosystems to Overcome Multidrug Resistance in Cancer: A Pilot StudyClinical Orthopaedics and Related Research, 2013
- The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesotheliomaBiomaterials, 2011
- The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulationBiomaterials, 2010